2024 ISPE Annual Meeting & Expo

Save the Date

The 2024 ISPE Annual Meeting & Expo is poised to herald a transformative era in pharmaceutical science and manufacturing. The increasing impact of new technology, treatment modalities and digitalization such as artificial intelligence (AI) and machine learning (ML) in the pharmaceutical industry has sparked interest in many areas of development and CMC. More than ever, an emphasis on cross discipline collaboration is needed for these groundbreaking technologies to be implemented and accepted worldwide. This year’s event also seeks to illuminate their profound impact on organizational readiness and the workforce of the future. By fostering global discussions centered on excellence, modernization, and harmonization, we aim to prepare pharma professionals for the challenges and opportunities of an evolving industry landscape.

Our comprehensive education program offers cutting-edge technical sessions, shedding light on the latest advancements in areas like supply chain, operations, facilities, and regulatory affairs, but also emphasizing the role of data science including model-informed drug development (MIDD) and technology in shaping the future of product development, production systems, and quality assurance.

This signature gathering is not just an opportunity to learn but also to connect. From emerging talents to seasoned executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies, attendees will get the chance to network, exchange insights, and preview the latest technologies and services at our expansive Partner Showcase.

Highlights: ISPE Annual Meeting & Expo through the Years

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2024 ISPE Annual Meeting & Expo.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Company Type

Program Committee

Ciby Abraham, PhD
Senior Director and Group Manager, Project and Product Leadership
Lisa J. Graham, PhD, PE
Chief Executive Officer
Seeq Corporation
Past Chair
Michael L. Rutherford
Retired, Computer Systems Quality & Data Integrity
Board Liason
David Churchward
Global Head Sterility Assurance, Cell and Gene Technologies
Lonza Biologics
Executive Chair
Chelsea Coffey, MSc, MBA, PMP
Clinical Drug Supply
Emerging Leader
Amanat Kaur
Bioprocess Engineer
Hyde Engineering & Consulting
Emerging Leader
Niranjan S. Kulkarni, PhD
Senior Director, Consulting Services
Connie Langer
Director, CMC - Global Regulatory
Shanshan Liu
No Deviation Pte Ltd
Ryan Paul Mazur
Process Engineer
Emerging Leader
Peter G. Millili, PhD
Senior Director, Manufacturing Science and Technology
Bristol-Myers Squibb
John Noble
Vice-President and General Manager, Life Sciences
Foundation Liason
Mark O'Connor
Operations Lead and Start-up Manager
Emerging Leader
Robert E. Perks, MSc, CEng
Senior Director, Business Development
Silas Tamufor
Quality Assurance, R&D Clinical Injectable Manufacturing
Emerging Leader
Charlie C. Wakeham
Global Head of Quality and Compliance
Aaron Weinstein
Senior Director, Compliance Consulting
IPS – Integrated Project Services, LLC